Hernandez, Diana
Khan, Farzana
Albert, David
Giovenco, Daniel
Branas, Charles
Valeri, Linda
Navas-Acien, Ana
Funding for this research was provided by:
National Institutes of Health (1R01CA240555-01A1)
Article History
Received: 16 March 2023
Accepted: 29 April 2023
First Online: 22 August 2023
Declarations
:
: Columbia University Institutional Review Board has approved this study (Protocol # AAAT1493) and provided ethical oversight. They have approved a waiver of written consent. Verbal informed consent to participate will be obtained from all participants prior to enrollment. The most recent IRB approval letter is attached as Additional File 1, Columbia University IRB Approval Letter.
: Eligible and consented participants are provided an information sheet outlining study risks and benefits. After review of participation, risks, benefits, etc., verbal consent is obtained.
: The authors declare that they have no competing interests.